Interview with Dr. Hernán González about thyroid cancer and his Thyrogen project with a distinction towards the Consortium.

The technology integrates the genetic information of the patients thanks to the use of artifiial intelligence tools that allow to create predictive profiles. It was 12 years of hard scientific and clinical studies of researchers at the Molecular Clinical Biomedicine Technologycal Consortium of the Catholic University (BRMC) to create a genetic test call ThyroidPrint, which determines wheter a nodule lodge in the thyroid of a patient is cancerous or not.

This will allow to detect and diagnose respiratory infections caused by viruses and bacteria more prevalent in Chile and the world in an easier, faster and effective. In addition, it will allow us to estimate the severity of the respiratory infection.

The syncytial virus, influenza, parainfluenza, metapneumovirus and adenovirus, are pathogens that can be investigated quickly in nasale secretions.

Drugs to treat various diseases and cardiovascular risk factors such as obesity, hypertension, diabetes and high cholesterol, which together are known as the Metabolic Syndrome.

Lorena González explains how was her process against a nodule in her thyroid and how she was able to access to the less invasive treatment with fuctionals tests according to genetic markers.

 

Interview with BRMC General Manager about patents.

Interview with Dr. Hernán González, about thyroid test.

Interview with Dr. Fardella and Dr. Baudrand, about hypertension.